SOURCES SOUGHT
A -- Preclinical Medication Discovery and Abuse Liability Testing for NIDA
- Notice Date
- 4/11/2006
- Notice Type
- Sources Sought
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6101 Executive Boulevard Room 260 - MSC 8402, Bethesda, MD, 20892
- ZIP Code
- 20892
- Solicitation Number
- 78859
- Response Due
- 4/25/2006
- Archive Date
- 5/10/2006
- Description
- This is a SOURCES SOUGHT NOTICE to determine the availability of small businesses (e.g., 8(a), veteran-owned small businesses, services-disabled veteran owned small businesses, HUB Zone small businesses, small disadvantaged businesses, and women-owned small businesses) having in-house capability to perform in vivo rodent and primate pharmacology studies of new drugs of abuse and potential pharmacotherapies for drug dependence disorders. Primate studies will include the evaluation of test compound effects in opiate-dependent monkeys. The data generated on new drugs of abuse will be provided to the DEA by NIDA. Data gathered on potential pharmacotherapies will be used by the NIDA Medications Development Program. The Contractor will be blinded to the identity of proprietary test compounds and all compounds will be evaluated in established assays, as specified by the NIDA Project Officer. The successful party must indicate possession of current DEA registration for Schedule II-V substances prior to award and apply for Schedule I registration. Information sent should be relevant and specific in the technical area under consideration, on each of the following qualifications: (1) Experience: An outline of previous similar projects, specific experience in performing in vivo rodent and primate pharmacology studies and pharmacotherapies for drug abuse; (2) Personnel: Name, professional qualifications and specific experience of scientists and/or technical personnel who may be assigned as project director and other key positions; (3) Facilities: Availability and description of facilities and equipment required to conduct this type of work; (4) capability to obtain DEA registration for Schedule II-V substances and eligibility to obtain Schedule I. Any other specific and relevant information about this particular area of procurement that would improve our consideration and evaluation of the information presented is desirable. Interested organizations must demonstrate and document, in any capability statements submitted, extensive experience with and the ability to perform the above tasks. Organizations should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner. Documentation may include, but not be limited to, contracts both Government and commercial the organization performed, references, i.e., names, titles, telephone numbers and any other information serving to document the organizations capability, e.g., awards, commendations, etc. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. This is not a request for proposals. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent for the Government?s use. Any proprietary information should be so marked. Interested organizations presenting a capability statement must provide the following: 1) company name and address; 2) point of contact, 3) phone/fax/email; 4) NAICS Codes, 5) business size and status, and 6) capability information in response to the requirement; and 6) type of small business your organization classifies itself as. Please submit written capability statements by April 25, 2006 to the NIDA Contracting Officer.
- Record
- SN01025452-W 20060413/060411220348 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |